Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Poietis logo — Make tissues real

Poietis

Make tissues real

Founded 2014 France France 15 employees Seed Total: $7.50M Biotechnology, Pharmaceutical +1

General Information

Company Name Poietis
Founded Year 2014
Location France France
Employees 15
Industries Biotechnology, Pharmaceutical, Wellness Beauty
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Poietis. To contact Poietis, visit poietis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Poietis compare?

A PDF of Poietis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Poietis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Poietis

Poietis, with its slogan "Make tissues real," is a pioneering health-tech company based in France. Established in 2014, it specializes in Biotechnology, Pharmaceutical, and Wellness Beauty industries. The company leverages advanced 4D Bioprinting technology to manufacture human tissues, targeting Cell Therapy and Research Centers as its primary market.

Poietis is not only focused on creating next-generation bioprinting systems but also collaborates with leading clinicians to develop advanced therapies. This dual approach enhances its strategic positioning in a rapidly growing market.

The company last secured a €5.00M Series A investment on 27 March 2018, with WiSEED as a notable investor. This funding underscores investor confidence and provides a financial foundation for expansion and research development. Overall, Poietis presents a compelling opportunity for investors interested in cutting-edge biotechnological innovations.

Business keywords: 4D bioprinting, Tissue engineering, Laser bioprinting, Cell therapy, Regenerative medicine, Physiological models, Preclinical research, Toxicity assessment, Cosmetic products evaluation, Industrial production, Clinical products manufacturing, Single-cell bioprinting, Skin tissue engineering, Partnering with pharmaceutical companies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €5.00M 1
Wiseed
01 Mar 2018
Seed €2.50M -
01 Jan 2016
Spinout Undisclosed 1
University Ventures
University Ventures
01 Sep 2014

Poietis Alternatives & Competitors

View All Alternatives
Poietis vs
Fluicell
Fluicell Sweden

Making tissue therapeutics possible to defeat serious disease

Post-IPO Equity
16 employees
Biotechnology, Health Care
Poietis vs
Advanced BioHealing
Advanced BioHealing

Pioneering breakthroughs in regenerative medicine with advanced cell-based and tissue-engineered sol...

Series C
Biotechnology, Pharmaceutical
Poietis vs
CytoSeek
CytoSeek United Kingdom

A cell-therapy technology company developing artificial membrane-binding proteins for oncology and r...

Seed
2 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Poietis

Make tissues real
Poietis was founded in 2014.
Poietis is headquartered in France.
Poietis operates in Biotechnology, Pharmaceutical and Wellness Beauty. Its work centres on 4D bioprinting, Tissue engineering, Laser bioprinting and Cell therapy.
Poietis has approximately 15 employees.
Poietis has completed 3 funding rounds, raising a total of $7.50M. The latest funding stage is Seed.
Top alternatives and competitors to Poietis include Fluicell, Advanced BioHealing, CytoSeek, IASO Biotechnology（驯鹿生物）. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Poietis and Fluicell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Poietis, https://bouncewatch.com/company/poietis, updated 24 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes